Net Cash Provided by (Used in) Financing Activities in USD of Predictive Oncology Inc. from 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Predictive Oncology Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2010 to Q1 2024.
  • Predictive Oncology Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$112K.
  • Predictive Oncology Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $149K, a 97.8% decline from 2022.
  • Predictive Oncology Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $6.72M, a 86.7% decline from 2021.
  • Predictive Oncology Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $50.3M, a 289% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

Predictive Oncology Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$112K -$112K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q1 2023 $0 -$86.9K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q1 2022 $86.9K -$30.2M -99.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $30.3M +$24.4M +413% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $5.91M +$2.28M +62.6% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q1 2019 $3.64M +$621K +20.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-08
Q1 2018 $3.02M -$800K -21% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q1 2017 $3.81M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q1 2013 $1.3M +$1.15M +769% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-15
Q1 2012 $150K -$540K -78.3% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q1 2011 $689K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15

Predictive Oncology Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $149K -$6.57M -97.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $6.72M -$43.6M -86.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $50.3M +$37.4M +289% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-21
2020 $13M +$3.63M +39% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $9.32M +$3.53M +60.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2018 $5.79M +$680K +13.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-01
2017 $5.11M +$3.4M +199% Jan 1, 2017 Dec 31, 2017 10-K/A 2019-04-02
2016 $1.71M Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2012 $1.07M -$821K -43.3% Jan 1, 2012 Dec 31, 2012 10-K 2013-03-22
2011 $1.9M +$1.08M +133% Jan 1, 2011 Dec 31, 2011 10-K 2013-03-22
2010 $813K Jan 1, 2010 Dec 31, 2010 10-K 2012-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.